UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apathy in Neuropsychiatric Disease: Diagnosis, Pathophysiology, and Treatment

Neurotoxicity research, 2011-02, Vol.19 (2), p.266-278

Chase, Thomas N.

2011

Volltextzugriff (PDF)

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

The Journal of neuroscience, 2002-10, Vol.22 (20), p.9099-9103

2002

Volltextzugriff (PDF)

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

Movement disorders, 2005-08, Vol.20 (8), p.932-936

2005

Volltextzugriff (PDF)

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease

Neurotherapeutics, 2017-04, Vol.14 (2), p.405-416

2017

Volltextzugriff (PDF)

Dopaminergic modulation of cortical function in patients with Parkinson's disease

Annals of neurology, 2002-02, Vol.51 (2), p.156-164

2002

Volltextzugriff (PDF)

Striatal glutamatergic mechanisms and extrapyramidal movement disorders

Neurotoxicity research, 2003, Vol.5 (1-2), p.139-145

2003

Volltextzugriff (PDF)

Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates

Experimental neurology, 2005-03, Vol.192 (1), p.73-78

2005

Volltextzugriff (PDF)

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Neurology, 2001-11, Vol.57 (10), p.1829-1834

2001

Volltextzugriff (PDF)

Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity

Neurobiology of disease, 2005-11, Vol.20 (2), p.562-573

2005

Volltextzugriff (PDF)

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Trends in neurosciences (Regular ed.), 2000-10, Vol.23 (10), p.S86-S91

2000

Volltextzugriff (PDF)

Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats

Journal of neuroscience research, 2003-06, Vol.72 (6), p.768-780

2003

Volltextzugriff (PDF)

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

Pharmacology, biochemistry and behavior, 2008-10, Vol.90 (4), p.540-544

2008

Volltextzugriff (PDF)

Striatal plasticity and extrapyramidal motor dysfunction

Parkinsonism & related disorders, 2004-07, Vol.10 (5), p.305-313

Chase, Thomas N

2004

Volltextzugriff (PDF)

Nuclear Factor kappa B Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum

The Journal of neuroscience, 1999-05, Vol.19 (10), p.4023-4033

1999

Volltextzugriff (PDF)

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Movement disorders, 2001-05, Vol.16 (3), p.515-520

2001

Volltextzugriff (PDF)

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

Movement disorders, 1998-09, Vol.13 (5), p.798-802

1998

Volltextzugriff (PDF)

Quetiapine Attenuates Levodopa-Induced Motor Complications in Rodent and Primate Parkinsonian Models

Experimental neurology, 2002-10, Vol.177 (2), p.557-564

2002

Volltextzugriff (PDF)

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Brain research, 1998-11, Vol.813 (1), p.150-159

1998

Volltextzugriff (PDF)

Distinct Pathological Features of the Gallyas- and Tau-positive Glia in the Parkinsonism-Dementia Complex and Amyotrophic Lateral Sclerosis of Guam

Journal of neuropathology and experimental neurology, 1997-03, Vol.56 (3), p.308-316

1997

Volltextzugriff (PDF)

Pathophysiology of motor response complications in Parkinson's disease: Hypotheses on the why, where, and what

Movement disorders, 2000-01, Vol.15 (1), p.3-8

2000

Volltextzugriff (PDF)

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

Brain research, 1994-10, Vol.662 (1), p.69-74

1994

Volltextzugriff (PDF)

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Brain research, 1999-03, Vol.821 (2), p.433-442

1999

Volltextzugriff (PDF)

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

Movement disorders, 2004-10, Vol.19 (10), p.1183-1186

2004

Volltextzugriff (PDF)

Continuous transdermal dopaminergic stimulation in advanced Parkinson's Disease

Clinical neuropharmacology, 2001-05, Vol.24 (3), p.163-169

2001

Volltextzugriff (PDF)

NMDA receptor blockade reverses motor response alterations induced by levodopa

Neuroreport, 1994-12, Vol.5 (18), p.2586-2588

1994

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

KollektionEBSCOhost Psychology and Behavioral Sciences Collection

SpracheFranzösisch

ThemaNeurosciences & Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(169)

Sprache

Englisch
(169)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apathy in Neuropsychiatric Disease: Diagnosis, Pathophysiology, and Treatment

Dopamine Modulates the Response of the Human Amygdala: A Study in Parkinson's Disease

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer’s Disease

Dopaminergic modulation of cortical function in patients with Parkinson's disease

Striatal glutamatergic mechanisms and extrapyramidal movement disorders

Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates

Serotonin 5-HT1A agonist improves motor complications in rodent and primate parkinsonian models

Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

Cyclic AMP responsive element binding protein phosphorylation and persistent expression of levodopa-induced response alterations in unilateral nigrostriatal 6-OHDA lesioned rats

A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model

Striatal plasticity and extrapyramidal motor dysfunction

Nuclear Factor kappa B Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum

Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

Quetiapine Attenuates Levodopa-Induced Motor Complications in Rodent and Primate Parkinsonian Models

Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: effect of dopaminergic denervation and l-DOPA administration

Distinct Pathological Features of the Gallyas- and Tau-positive Glia in the Parkinsonism-Dementia Complex and Amyotrophic Lateral Sclerosis of Guam

Pathophysiology of motor response complications in Parkinson's disease: Hypotheses on the why, where, and what

Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal nmda receptor subunits

Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease

Continuous transdermal dopaminergic stimulation in advanced Parkinson's Disease

NMDA receptor blockade reverses motor response alterations induced by levodopa

Aktive Filter

Suchergebnisse filtern